HPV vaccine recommendations.

TitleHPV vaccine recommendations.
Publication TypeJournal Article
Year of Publication2012
Corporate AuthorsCommittee on Infectious Diseases
JournalPediatrics
Volume129
Issue3
Pagination602-5
Date Published2012 Mar
ISSN1098-4275
KeywordsAdolescent, Advisory Committees, Age Factors, Centers for Disease Control and Prevention (U.S.), Female, Forecasting, Health Policy, Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18, Humans, Immunization Programs, Immunization Schedule, Male, Papillomavirus Infections, Papillomavirus Vaccines, Patient Compliance, Practice Guidelines as Topic, Risk Assessment, Sex Factors, United States
Abstract

On October 25, 2011, the Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention recommended that the quadrivalent human papillomavirus vaccine (Gardasil; Merck & Co, Inc, Whitehouse Station, NJ) be used routinely in males. The American Academy of Pediatrics has reviewed updated data provided by the Advisory Committee on Immunization Practices on vaccine efficacy, safety, and cost-effectiveness as well as programmatic considerations and supports this recommendation. This revised statement updates recommendations for human papillomavirus immunization of both males and females.

DOI10.1542/peds.2011-3865
Alternate JournalPediatrics
PubMed ID22371460